Hide filtersShow filters × Close Bryan, Garnier & Co successfully leads Novagali Pharma €22m IPO Bryan, Garnier & Co leads a Eur 152m capital increase for Transgene Bryan, Garnier & Co successfully leads €6.7 million IPO for Integragen Bryan, Garnier & Co leads a € 24,3 m capital increase for Innate Pharma Bryan, Garnier & Co leads a € 15,6 m capital increase for ExonHit Therapeutics Bryan, Garnier & Co advised a hyperbaric oxygen therapy company on its sale to Candescent Partners. Bryan, Garnier & Co advises Mérieux Alliance for the divestiture of ShanH (the majority shareholder of the Indian vaccine company Shantha Biotechnics) to Sanofi-aventis Bryan, Garnier & Co has successfully advised majority shareholder GRED in the public tender offer & squeeze out of Softway Medical Bryan, Garnier & Co. announces it has advised ExonHit Therapeutics on the free allocation of subscription warrants to all its shareholders Bryan, Garnier & Co. announces successful admission of ONI BioPharma Inc.’s common stock to listing and trading on NYSE Alternext Paris Bryan, Garnier & Co successfully advised Pierrel on its EUR 17.1 million follow-on offering Bryan Garnier successfully leads €12 million IPO for Ipsogen
